Raymond James analyst Jayson Bedford reiterated a Market Perform rating on Medtronic, Inc. (NYSE: MDT).The analyst comments "The F1Q setup ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Medtronic, Inc. (mdt) PT Raised to $107 at Evercore ISIAugust 19, 2025 4:15 PM TD Cowen Reiterates Buy Rating on Medtronic, Inc. (MDT)August 19, 2025 8:32 AM Truist Securities Reiterates Hold Rating on Medtronic, Inc. (MDT)August 19, 2025 8:30 AM Goldman on Medtronic, Inc. (MDT), 'believe investors had expected total organic growth acceleration to follow the strong performance in CAS'August 19, 2025 8:05 AM Raymond James on Medtronic, Inc. (MDT) Earnings: 'All in, this result and guide fell short of our elevated expectations'August 19, 2025 8:04 AM Stifel Reiterates Hold Rating on Medtronic, Inc. (MDT)August 19, 2025 8:01 AM Mizuho on Medtronic, Inc. (MDT): 'Largely Inline Print Likely Overshadowed by New Board Appointees'August 19, 2025 7:58 AM